BRL-26830A
BRL-26830A is a β-adrenergic receptor agonist. BRL-26830A reduces body weight and increases metabolic rate in obese mouse models. BRL-26830A stimulates insulin release and significantly reduces blood glucose levels in ICR mouse models. BRL-26830A can be used to study endocrine and metabolic diseases such as obesity and diabetes.
For research use only. We do not sell to patients.
- CAS No.: 87857-42-9
- Formula: C19H23NO3.1/2C4H4O4
- Molecular Weight:371.45
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
All Adrenergic Receptor Isoforms
More
Biological Activity
Chemical Information
-
CAS No. 87857-42-9
-
Molecular Weight 371.45
-
Formula C19H23NO3.1/2C4H4O4
-
SMILES
O=C(O)/C=C/C(O)=O.O=C(OC)C1=CC=C(C[C@@H](NC[C@@H](O)C2=CC=CC=C2)C)C=C1.[1/2]
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Connacher AA, et al. Clinical studies with the beta-adrenoceptor agonist BRL 26830A. Am J Clin Nutr. 1992 Jan;55(1 Suppl):258S-261S. [Content Brief]
[2]. Arch JR, et al. Thermogenic and antiobesity activity of a novel beta-adrenoceptor agonist (BRL 26830A) in mice and rats. Am J Clin Nutr. 1983 Oct;38(4):549-58. [Content Brief]
[3]. Yoshida T. The antidiabetic beta 3-adrenoceptor agonist BRL 26830A works by release of endogenous insulin. Am J Clin Nutr. 1992 Jan;55(1 Suppl):237S-241S. d [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
BRL-26830A Related Classifications
HY-19002 Related Classifications
Powered by Bioz